Skip to content
★ Sign in to follow
COSMOS Pharmaceutical Corporation logo

COSMOS Pharmaceutical Corporation Stock: price and insider trades · Japan

株式会社コスモス薬品

JP·Mcap JP¥503.3BHealth Care

COSMOS Pharmaceutical Corporation: what insiders have been doing

COSMOS Pharmaceutical Corporation, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to EDINET (Japan FSA). 5 insiders have disclosed 8 filings since 26 October 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

For context, the typical company on the same exchange (median of 3,205 companies) published 3 filings over the same period, against 8 filings here.

There has been no open-market purchase by an insider of COSMOS Pharmaceutical Corporation for at least a year. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. Until a filing is published, the market cannot know about the trade.

Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.

Insider Decl.
25
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate COSMOS Pharmaceutical Corporation Buy (bullish), based on 10 analysts. Average price target: JP¥7,510.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,527 of 26,911 companies
53.3
score / 100
Value
56
Quality
51
FCF yld-2.3%
Earn yld6.4%
EV/EBITDA8.4x
ROE12%
Gross mgn21%
Net mgn2.9%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended May 2026 · cache

JP¥6,350
Analyst consensus
10 analysts
Buy
JP¥6,700Target JP¥7,510(+18%)JP¥9,600
Income statement
RevenueJP¥1.1T
Gross profitJP¥229.7B21% margin
EBITDAJP¥69.4B6% margin
Net incomeJP¥32B2.9% margin
Valuation
PER (trailing)15.7x
P/Book1.7x
Beta0.16
Balance sheet & cash
Market capJP¥503.3B
Total debtJP¥78.5B
Free Cash Flow-JP¥11.7B
Debt / Equity24%
Profitability & ownership
ROE11.7%
ROA4.7%
% insiders55.4%
% institutions31.6%
Last declaration on 7 October 2026
Declarations25 total

25 of 25 declarations

About COSMOS Pharmaceutical Corporation

Cosmos Pharmaceutical Corporation is a Japanese company that specializes in the sale of pharmaceutical and healthcare products. It primarily operates in the Japanese market and focuses on the distribution of medicines and wellness products.